The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): A critical literature review

Archives of Gynecology and Obstetrics

Volumn 282, Issue 6, 2010, Pages 659-664

  Vorgias, G ^a   Fotiou, S ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Carcinosarcoma; Lymphadenectomy; Mixed mullerian tumour; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CARCINOSARCOMA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; HUMAN; LEIOMYOSARCOMA; LIVER METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MICROMETASTASIS; MIXED MULLERIAN TUMOR; OVERALL SURVIVAL; PERITONEUM METASTASIS; PROGNOSIS; SYSTEMATIC REVIEW; UTERUS SARCOMA;

CARCINOSARCOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; UTERINE NEOPLASMS;

EID: 78449278147     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1649-0     Document Type: Article

References (47)

1. SD Yamada RA Burger WR Brewster D Anton MF Kohler BJ Monk 2000 Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus Cancer 88 12 2782 2786 1:STN:280:DC%2BD3czivFylsg%3D%3D 10.1002/1097-0142(20000615)88: 12<2782::AID-CNCR17>3.0.CO;2-K 10870061 (Pubitemid 30417939)
2. CD Arrastia RG Fruchter M Clark M Maiman JC Remy M Macasaet EJ Gates T Di Maio T Marzec 1997 Uterine carcinosarcomas: incidence and trends in management and survival Gynecol Oncol 65 1 158 163 1:STN:280:DyaK2s3ls1Gltw%3D%3D 10.1006/gyno.1997.4629 9103406 (Pubitemid 27171567)
3. RR Nordal SO Thoresen 1997 Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality Eur J Cancer 33 6 907 911 1:STN:280: DyaK2svjslarsw%3D%3D 10.1016/S0959-8049(97)00040-3 9291814 (Pubitemid 27287045)
4. TV Dinh RE Slavin BS Bhagavan EV Hannigan EM Tiamson RB Yandell 1989 Mixed müllerian tumors of the uterus: a clinicopathologic study Obstet Gynecol 74 3 Pt 1 388 392 1:STN:280:DyaL1MzksVOntw%3D%3D 2548134
5. KV Kahanpää T Wahlström P Gröhn E Heinonen U Nieminen O Widholm 1986 Sarcomas of the uterus: a clinicopathologic study of 119 patients Obstet Gynecol 67 3 417 424 3945454
6. W Schweizer R Demopoulos U Beller N Dubin 1990 Prognostic factors for malignant mixed müllerian tumors of the uterus Int J Gynecol Pathol 9 2 129 136 1:STN:280:DyaK3c3js1Gmtg%3D%3D 10.1097/00004347-199004000-00004 2158940 (Pubitemid 20169406)
7. M Callister LM Ramondetta A Jhingran TW Burke PJ Eifel 2004 Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome Int J Radiat Oncol Biol Phys 58 3 786 796 14967435
8. K Galaal FM Kew KF Tam A Lopes M Meirovitz R Naik KA Godfrey MH Hatem RJ Edmondson 2009 Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma Eur J Obstet Gynecol Reprod Biol 143 2 88 92 1:STN:280:DC%2BD1M3htV2mug%3D%3D 10.1016/j.ejogrb.2008.12.014 19201517 Epub 2009 Feb 7
9. D Nemani N Mitra M Guo L Lin 2008 Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis Gynecol Oncol 111 1 82 88 10.1016/j.ygyno.2008.05.016 18674808
10. P Morice A Rodrigues P Pautier A Rey S Camatte D Atallah C Pomel C Lhommé C Haie-Meder P Duvillard D Castaigne 2003 Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure Gynecol Obstet Fertil 31 2 147 150 1:STN:280:DC%2BD3s7pvFGguw%3D%3D 10.1016/S1297-9589(03)00061-4 12718990 (Pubitemid 36548054)
11. JD Wright VE Seshan M Shah PB Schiff WM Burke CJ Cohen TJ Herzog 2008 The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma Am J Obstet Gynecol 199 5 536.e1 536.e8 10.1016/j.ajog.2008.04. 019 Epub 3 June 2008
12. JY Park DY Kim JH Kim YT kim JH Nam 2010 The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early stage carcinosarcoma of uterus Ann Surg Oncol 17 3 861 868 10.1245/s10434-009-0833-6 19921530
13. Winter R, Ostor A, Kapp K, Petru E (2004) Primary treatment of uterine sarcomas. In: Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G (eds) Gynecologic cancer. Controversies in management. Elsevier, New York, pp 301-316
14. Sutton G, Kavanagh J, Wolfson A, Tornos C (2005) Corpus: mesenchymal tumors. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME (eds) Principles and practice of gynecologic oncology, 4th edn. Lippincott, Philadelphia, pp 873-894
15. Hacker NF (2005) Uterine cancer. In: Berek JS, Hacker NF (eds) Practical gynecologic oncology, 4th edn. Lippincott, Philadelphia, pp 397-442
16. Hacker NF, Marsden DE (2006) Surgery for uterine cancer. In: Luesley DM, Lawton FG, Berchuck A (eds) Uterine cancer. Taylor & Francis, London, pp 142-144
17. HC Kitchener EL Trimble 2009 Endometrial cancer state of the art meeting Int J Gynecol Cancer 19 1 134 140 19258955
18. Y Iwasa H Haga I Konishi Y Kobashi K Higuchi E Katsuyama S Minamiguchi H Yamabe 1998 Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients Cancer 82 3 512 519 1:STN:280:DyaK1c7ht1Knug%3D%3D 10.1002/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.0.CO;2-4 9452269 (Pubitemid 28112990)
19. WG McCluggage 2002 Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas Int J Gynecol Cancer 12 6 687 690 1:STN:280:DC%2BD38novVSjug%3D%3D 10.1046/j.1525-1438.2002.01151.x 12445244 (Pubitemid 35388035)
20. WG McCluggage 2002 Recent advances in immunohistochemistry in gynaecological pathology Histopathology 40 4 309 326 1:STN:280: DC%2BD383gvFGrsg%3D%3D 10.1046/j.1365-2559.2002.01384.x 11943015 (Pubitemid 34595581)
21. L Brown 2008 Pathology of uterine malignancies Clin Oncol (R Coll Radiol) 20 6 433 447 1:STN:280:DC%2BD1cvjtFGktg%3D%3D Epub 2008 May 21
22. LE Kernochan RL Garcia 2009 Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics J Natl Compr Canc Netw 7 5 550 556 1:CAS:528: DC%2BD1MXhtVKgtbjE 19460280
23. M Nola D Babić J Ilić M Marusić B Uzarević M Petrovecki A Sabioncello D Kovac S Jukić 1996 Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus Cancer 78 12 2543 2550 1:STN:280:DyaK2s7htVCjsA%3D%3D 10.1002/(SICI)1097-0142(19961215)78: 12<2543::AID-CNCR14>3.0.CO;2-W 8952563 (Pubitemid 26415687)
24. F Amant I Cadron L Fuso P Berteloot E de Jonge G Jacomen J Van Robaeys P Neven P Moerman I Vergote 2005 Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer Gynecol Oncol 98 2 274 280 10.1016/j.ygyno.2005.04.027 15972232 (Pubitemid 41019116)
25. A Rovirosa C Ascaso J Ordi R Abellana M Arenas JA Lejarcegui J Pahisa LM Puig-Tintoré B Mellado B Armenteros X Iglesias A Biete 2002 Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages Int J Radiat Oncol Biol Phys 52 5 1320 1329 10.1016/S0360-3016(01)02808-5 11955745 (Pubitemid 34296491)
26. Benito V, Lubrano A, Arencibia O, Andújar M, Alvarez E, Medina N, Falcón JM, Falcón O (2009) Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Int J Gynaecol Obstet (Epub ahead of print)
27. JY Park DY Kim DS Suh JH Kim YM Kim YT Kim JH Nam 2008 Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007 J Cancer Res Clin Oncol 134 12 1277 1287 10.1007/s00432-008-0422-2 18506484 Epub 2008 May 28
28. K Kokawa K Nishiyama M Ikeuchi Y Ihara N Akamatsu T Enomoto O Ishiko S Motoyama S Fujii N Umesaki 2006 Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003) Int J Gynecol Cancer 16 3 1358 1363 1:STN:280:DC%2BD28zoslemsg%3D%3D 10.1111/j.1525-1438.2006.00536.x 16803530 (Pubitemid 43886769)
29. TI Wu KH Hsu HJ Huang S Hsueh HH Chou CS Tsai KC Ho A Chao TC Chang CH Lai 2008 Prognostic factors and adjuvant therapy in uterine carcinosarcoma Eur J Gynaecol Oncol 29 5 483 488 1:STN:280:DC%2BD1cjotl2ksA%3D%3D 19051818
30. RR Nordal GB Kristensen AE Stenwig JM Nesland EO Pettersen CG Trope 1997 An evaluation of prognostic factors in uterine carcinosarcoma Gynecol Oncol 67 3 316 321 1:STN:280:DyaK1c7gsVaktA%3D%3D 10.1006/gyno.1997.4875 9441781 (Pubitemid 28034640)
31. D Yalman Z Ozsaran B Baltalarli O Demir N Ozdemir A Aras 2008 Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients Eur J Gynaecol Oncol 29 1 46 51 1:STN:280: DC%2BD1c3ivVahtw%3D%3D 18386463
32. G El Husseiny N Al Bareedy WA Mourad G Mohamed M Shoukri J Subhi A Ezzat 2002 Prognostic factors and treatment modalities in uterine sarcoma Am J Clin Oncol 25 3 256 260 1:STN:280:DC%2BD38zisFygtA%3D%3D 10.1097/00000421-200206000- 00010 12040283 (Pubitemid 34602546)
33. P Inthasorn J Carter S Valmadre P Beale P Russell C Dalrymple 2002 Analysis of clinicopathologic factors in malignant mixed Müllerian tumors of the uterine corpus Int J Gynecol Cancer 12 4 348 353 1:STN:280: DC%2BD38zps1aksA%3D%3D 10.1046/j.1525-1438.2002.01117.x 12144682 (Pubitemid 34839832)
34. M Ozguroglu A Bilici S Ilvan H Turna B Atalay N Mandel I Sahinler 2008 Determining predominating histologic component in malignant mixed Müllerian tumors: is it worth it? Int J Gynecol Cancer 18 4 809 812 1:STN:280: DC%2BD1crisl2jtA%3D%3D 10.1111/j.1525-1438.2007.01074.x 17892455 Epub 2007 Sep 24 (Pubitemid 352020163)
35. Leath CA 3rd, Numnum TM, Kendrick JE 4th, Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr (2009) Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy. Int J Gynecol Cancer 19(5):888-891
36. A Gadducci S Cosio A Romanini AR Genazzani 2008 The management of patients with uterine sarcoma: a debated clinical challenge Crit Rev Oncol Hematol 65 2 129 142 10.1016/j.critrevonc.2007.06.011 17706430 Epub 2007 Aug 13. Review
37. FJ Major JA Blessing SG Silverberg CP Morrow WT Creasman JL Currie E Yordan MF Brady 1993 Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 4 Suppl 1702 1709 1:STN:280:DyaK3s7mtFeisg%3D%3D 8381710
38. WT Creasman F Odicino P Maisonneuve MA Quinn U Beller JL Benedet AP Heintz HY Ngan S Pecorelli 2006 Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl 1 S105 S143 10.1016/S0020-7292(06)60031-3 17161155 (Pubitemid 44854931)
39. A Ayhan ZS Tuncer M Tanir K Yüce A Ayhan 1997 Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients Eur J Gynaecol Oncol 18 2 146 148 1:STN:280:DyaK2s3lvFOksg%3D%3D 9105869
40. SM Temkin M Hellmann YC Lee O Abulafia 2007 Early-stage carcinosarcoma of the uterus: the significance of lymph node count Int J Gynecol Cancer 17 1 215 219 1:STN:280:DC%2BD2s%2FpsVChug%3D%3D 10.1111/j.1525-1438.2006.00762.x 17291256 (Pubitemid 46213993)
41. J Akahira H Tokunaga M Toyoshima T Takano S Nagase K Yoshinaga T Tase Y Wada K Ito H Niikura H Yamada A Sato H Sasano N Yaegashi 2006 Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma Oncology 71 5-6 333 340 10.1159/000107107 17690557 Epub 2007 Aug 9
42. S Sagae K Yamashita S Ishioka Y Nishioka K Terasawa M Mori K Yamashiro T Kanemoto R Kudo 2004 Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan Oncology 67 1 33 39 10.1159/000080283 15459493 (Pubitemid 39370348)
43. TP Manolitsas GV Wain KE Williams M Freidlander NF Hacker 2001 Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus Cancer 91 8 1437 1443 1:STN:280: DC%2BD3M3mtFCktw%3D%3D 10.1002/1097-0142(20010415)91:8<1437::AID- CNCR1150>3.0.CO;2-P 11301390 (Pubitemid 32319253)
44. Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB (2008) European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 44(6):808-18 (Epub 2008 Apr 2). Erratum in: Eur J Cancer. 2008 Jul; 44(11):1612
45. K Gerszten C Faul S Kounelis Q Huang J Kelley MW Jones 1998 The impact of adjuvant radiotherapy on carcinosarcoma of the uterus Gynecol Oncol 68 1 8 13 1:STN:280:DyaK1c7itlSmtg%3D%3D 10.1006/gyno.1997.4901 9454652 (Pubitemid 28109815)
46. S Shimizu M Yajima A Yoshii T Nishikawa H Ohta 2009 Malignant pericardial effusion and cardiac tamponade originating from uterine carcinosarcoma Arch Gynecol Obstet 279 3 373 375 10.1007/s00404-008-0701-9 18548260 Epub 2008 Jun 12
47. Yoney A, Eren B, Eskici S, Salman A, Unsal M (2008) Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer 95(3):E10-17